Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled

An alarming 40% of orders for glucagon-like peptide-1 receptor agonists (GLP-1RAs) went unfilled between January 2018 and September 2022, according to a new study from the University of Colorado Health (UCHealth) system, with patients citing soaring costs, insurance roadblocks, and potential prejudicial prescribing behavior because of race as access barriers.¹ In addition, despite a higher prevalence of diabetes and obesity among racial and ethnic minority groups and for individuals who have obesity and not diabetes, the impact from lack of access has the potential to be more significant.